Premium
Women’s satisfaction with and ongoing use of hormonal long‐acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd)
Author(s) -
Black Kirsten I.,
McGeechan Kevin,
Watson Cathy J.,
Lucke Jayne,
Taft Angela,
McNamee Kathleen,
Haas Marion,
Peipert Jeffrey F.,
Mazza Danielle
Publication year - 2021
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.13319
Subject(s) - levonorgestrel , medicine , discontinuation , long acting reversible contraception , pill , oral contraceptive pill , family planning , hormonal contraception , intrauterine device , implant , gynecology , unintended pregnancy , obstetrics , patient satisfaction , contraceptive implant , population , nursing , research methodology , surgery , environmental health
Background The Australian Contraceptive ChOice pRoject (ACCORd) aimed to assess the impact of a complex general practice intervention on the uptake of long‐acting reversible contraceptives (LARC). Aims Using survey data from enrolled women, we aimed to compare the ongoing use and satisfaction of women who chose one of the hormonal LARC methods including the levonorgestrel intrauterine system (LNG‐IUS) or levonorgestrel implant compared to the oral contraceptive pill (OCP). Materials and Methods We used the data from participants’ baseline, six and 12‐month surveys to identify new users of implants, LNG‐IUS or OCP. We included demographic information, ongoing use of the contraceptive method, reasons for dissatisfaction and discontinuation and experience of side‐effects. Proportions were compared using χ 2 tests. Results Of the 740 women enrolled in ACCORd, 176 started using a hormonal LARC or OCP in the study’s first six months with 76 using the IUS (43%), 60 the implant (34%) and 40 (23%) the OCP. Twelve‐month continuation rates for the LNG‐IUS, implant and OCP were 93, 83 and 65% respectively ( P < 0.001). Satisfaction was highest among the LNG‐IUS users; 86% were very/somewhat satisfied compared to 75% of implant users and 61% of OCP users ( P < 0.001). Main reasons for method dissatisfaction were irregular bleeding and mood changes which were similar for all methods. Conclusions This study provides further evidence that hormonal LARC methods have higher continuation and satisfaction rates compared to the OCP with similar side‐effects. Since hormonal LARC methods have the highest contraceptive efficacy, these should be offered first‐line to women.